SciBase wins first US payer coverage as Highmark backs Nevisense policy
SciBase secured its first US private payer coverage for Nevisense after Highmark Blue Cross Blue Shield issued a positive medical policy. The decision shifts eligible use from mostly cash-pay to reimbursed care, easing a key barrier to wider adoption in the US. The policy deems electrical impedance spectroscopy medical